Can lacosamide and oxcarbazepine be used together for seizure control, and what are the recommended dosing and monitoring guidelines?

Lacosamide and Oxcarbazepine Combination Therapy

Yes, lacosamide and oxcarbazepine can be safely and effectively used together for focal-onset seizures, with evidence supporting this combination in both adults and children as young as 2 years of age.

Efficacy of the Combination

The combination of lacosamide (LCM) and oxcarbazepine (OXC) is well-supported for seizure control:

• In pediatric patients with focal epilepsy, the LCM-OXC combination showed that over 50% of patients achieved greater than 50% reduction in seizure frequency during long-term follow-up 1. This combination proved particularly effective in patients with underlying structural abnormalities.

• Both drugs are FDA-approved for focal-onset seizures: Oxcarbazepine is indicated as monotherapy or adjunctive therapy for partial-onset seizures in adults and children ≥2 years 2, while lacosamide is approved for monotherapy and adjunctive therapy in patients ≥4 years 3.

• Mechanistic complementarity: Both are sodium channel blockers but with different mechanisms—lacosamide primarily targets the slow inactivation state of sodium channels, while oxcarbazepine works through its active metabolite (MHD) on fast inactivation 4. This mechanistic difference may provide additive seizure control without redundancy.

Dosing Guidelines

Lacosamide Dosing:

• Pediatric maintenance dose: 3.8-10 mg/kg/day 1
• Adult dosing: Typically 200-400 mg/day in divided doses (based on standard practice)
• Available in both oral and intravenous formulations 3

Oxcarbazepine Dosing:

• Pediatric maintenance dose: 15-40 mg/kg/day 1
• Adult dosing for adjunctive therapy:
  • 600 mg/day showed 26.8% responder rate
  • 1,200 mg/day showed 41.2% responder rate
  • 2,400 mg/day showed 50% responder rate 5
• Administer twice daily, with or without food 2

Critical Monitoring Requirements

Sodium Levels (Priority #1):

Monitor serum sodium regularly—this is the most important safety concern with oxcarbazepine 2. Hyponatremia was the most frequently reported adverse reaction in the LCM-OXC combination 1.

Watch for symptoms of hyponatremia:

• Nausea and headache
• Confusion and tiredness
• Increased seizure frequency 2

Drug Interactions:

If the patient is on phenytoin, monitor phenytoin levels closely—oxcarbazepine at doses >1,200 mg/day increases phenytoin levels and may require phenytoin dose reduction 2.

If the patient is on enzyme-inducing drugs (carbamazepine, phenobarbital, rifampin), these will decrease the active metabolite (MHD) of oxcarbazepine by 25-49%, potentially requiring higher oxcarbazepine doses 2.

Hormonal Contraception:

Counsel female patients that oxcarbazepine reduces hormonal contraceptive efficacy—alternative or additional contraceptive methods are necessary 2.

Allergic Reactions:

Screen for carbamazepine allergy before starting oxcarbazepine—many patients allergic to carbamazepine will also react to oxcarbazepine 2. However, notably, no patients in the pediatric combination study experienced rash 1.

Monitor for serious allergic reactions:

• Swelling of face, eyes, lips, or tongue
• Skin rash or hives
• Fever, swollen glands, persistent sore throat
• Yellowing of skin/eyes (hepatotoxicity)
• Unusual bruising/bleeding 2

Psychiatric Monitoring:

Both medications carry the class warning for suicidal ideation. Monitor for:

• New or worsening depression
• Suicidal thoughts or behavior
• Unusual mood or behavior changes 2

Safety Profile

The combination demonstrated good tolerability 1:

• Most common adverse effects: hyponatremia, headache, dizziness, somnolence, and nausea
• Importantly, no rash occurred in the pediatric combination study 1
• Lacosamide can cause bradycardia (23.9% in one pediatric study) 6
• Oxcarbazepine discontinuation rates increase with higher doses (67% at 2,400 mg/day) 5

Clinical Advantages

This combination is particularly valuable for:

• Patients with focal epilepsy and structural brain abnormalities 1
• Patients who cannot tolerate carbamazepine due to elevated liver enzymes (lacosamide does not cause this issue) 7
• Situations requiring both oral and IV options (lacosamide available IV) 3

Practical Algorithm

1. Verify no carbamazepine allergy before starting oxcarbazepine
2. Obtain baseline serum sodium before initiating oxcarbazepine
3. Start with lower doses and titrate based on response:
   • Begin oxcarbazepine at 300-600 mg/day in adults (or 8-10 mg/kg/day in children)
   • Add lacosamide starting at 50-100 mg/day in adults (or 2 mg/kg/day in children)
4. Monitor sodium levels at 2-4 weeks, then periodically
5. Check for drug interactions, especially with phenytoin or enzyme inducers
6. Counsel about contraception if applicable
7. Titrate to effective doses based on seizure control and tolerability

Do not abruptly discontinue either medication—this can precipitate status epilepticus 2.